title: Newly diagnosed hyperglycemia and stress hyperglycemia in a coronary intensive care unit.
abstract: OBJECTIVE
  To determine prevalence of newly diagnosed hyperglycemia (NDH) among patients with acute coronary disease, inquire relationship of stress hyperglycemia (SH) with functional outcomes.
  
  
  METHODS
  Admission (APG) and first morning fasting plasma glucose (FPG) measurements were obtained, capillary glucose measurements (CGM) every 6-h within first day were performed-Group 1: Normoglycemics. Group 2: NDH cases: No known diabetes, APG>200mg/dl and/or FPG>126 and/or any of CGM>200. Group 2a: unrecognized glycemic disorder, HbA1c>6.0%. Group 2b: stress hyperglycemia, HbA1c<6.0%. Group 3: Recognized diabetes. Duration of ICU stays, APACHE-II scores were recorded. Logistic regression analysis was performed using ICU stay as dependent variable and age, groups, co-morbidities, problems in hospital, APACHE-II scores, CGMs were used as independent risk factors.
  
  
  RESULTS
  There were 255 (51.6%) in Group 1, 82 (16.6%) in Group 2; 37 (7.5%) cases in Group 2a, 45 (9.1%) in Group 2b and 157 (31.8%) in Group 3. Group 2b spent longer time in ICU, had higher APACHE-II scores (p=0.0001, p=0.0001). Regression analysis demonstrated SH as an independent risk factor for duration of ICU stay (OR: 2.8, 95% CI: 1.3-6.2).
  
  
  CONCLUSIONS
  Hyperglycemia was present in 48.4%; 16.6% had NDH, 9.1% had SH. Poor functional conditions of SH cases pointed that they need to be considered carefully.
authors.affiliation: Baskent University Faculty of Medicine, Division of Endocrinology and Metabolism, Adana, Turkey. e_ertorer@yahoo.com
authors.forename: M E
authors.initials: ME
authors.lastname: Ertorer
authors.forename: F E
authors.initials: FE
authors.lastname: Haydardedeoglu
authors.forename: T
authors.initials: T
authors.lastname: Erol
authors.forename: I
authors.initials: I
authors.lastname: Anaforoglu
authors.forename: S
authors.initials: S
authors.lastname: Binici
authors.forename: N B
authors.initials: NB
authors.lastname: Tutuncu
authors.forename: A
authors.initials: A
authors.lastname: Sezgin
authors.forename: N G
authors.initials: NG
authors.lastname: Demirag
mesh_terms: D000208:Acute Disease / Q000523:psychology / Q000628:therapy; D000368:Aged; D001786:Blood Glucose / Q000032:analysis; D003327:Coronary Disease / Q000097:blood / Q000150:complications* / Q000523:psychology / Q000628:therapy*; D058065:Diabetic Cardiomyopathies / Q000097:blood / Q000453:epidemiology / Q000628:therapy; D005260:Female; D006442:Glycated Hemoglobin / Q000032:analysis; D006785:Hospitals, University; D006801:Humans; D006943:Hyperglycemia / Q000097:blood / Q000150:complications* / Q000453:epidemiology*; D007362:Intensive Care Units / Q000706:statistics & numerical data*; D007902:Length of Stay; D008297:Male; D008875:Middle Aged; D015995:Prevalence; D012307:Risk Factors; D012720:Severity of Illness Index; D013315:Stress, Psychological / Q000097:blood / Q000150:complications* / Q000453:epidemiology*; D013997:Time Factors; D014421:Turkey / Q000453:epidemiology
chemical_list: D001786:Blood Glucose; D006442:Glycated Hemoglobin; C517652:hemoglobin A1c protein, human